Literature DB >> 21310396

[Oesophagogastric anastomosis complications in the Ivor Lewis operation].

Alvaro Díaz de Liaño Argüelles1, Gustavo Sánchez García, Concepción Yárnoz Irazábal, Alicia Artajona Rosino.   

Abstract

INTRODUCTION: Oesophagectomy is the principal treatment for cancer of the oesophagus. The oesophagogastric anastomotic leak is a serious complication of the Ivor Lewis operation, and is associated with increased mortality. The objective of this study is to analyse its incidence, its diagnosis and treatment results.
MATERIAL AND METHODS: A descriptive analysis of a consecutive series of oesophagectomies, carried out during a 5 year period, using the Ivor Lewis technique. All patients had hand sewn anastomosis. Data were collected on general morbidity, anastomosis leak, hospital mortality, survival, and stenosis of the anastomosis.
RESULTS: A total of 41 intrathoracic anastomoses were performed. Complications, of any type, were observed in 49% of cases, of which 3 (7.3%) were anastomotic leaks, one of them asymptomatic. One patient was urgently reoperated, and two others were treated with drains and conservative treatment. The mortality of the series was 7.3%, none associated with the anastomotic leak. The survival at 5 years was 27%, and 34% of the patients developed stenosis of the anastomosis.
CONCLUSIONS: Intrathoracic anastomosis after oesophagectomy, in our experience, can be performed with a low incidence of anastomotic leaks and without mortality due to this cause. Their treatment must be individualised and a considerable proportion do not require surgical intervention.
Copyright © 2010 AEC. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21310396     DOI: 10.1016/j.ciresp.2010.10.010

Source DB:  PubMed          Journal:  Cir Esp        ISSN: 0009-739X            Impact factor:   1.653


  1 in total

1.  A non-randomized retrospective observational study on the subcutaneous esophageal reconstruction after esophagectomy: is it feasible in high-risk patients?

Authors:  Jae Ho Chung; Sung Ho Lee; Eunjue Yi; Jae Seung Jung; Jung Wook Han; Tae Sik Kim; Ho Sung Son; Kwang Taik Kim
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.